CAR-T immunotherapies: Biotechnological strategies to improve safety, efficacy and clinical outcome through CAR engineering. (2019)
Attributed to:
New Industrial Systems: Optimising Me Manufacturing Systems
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.biotechadv.2019.06.010
PubMed Identifier: 31251969
Publication URI: http://europepmc.org/abstract/MED/31251969
Type: Journal Article/Review
Volume: 37
Parent Publication: Biotechnology advances
Issue: 7
ISSN: 0734-9750